MENU
+Compare
BIAF
Stock ticker: NASDAQ
AS OF
Jun 5 closing price
Price
$0.28
Change
-$0.02 (-6.67%)
Capitalization
23.27M

BIAF bioAffinity Technologies Forecast, Technical & Fundamental Analysis

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment... Show more

BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BIAF with price predictions
Jun 05, 2025

BIAF's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for BIAF moved out of oversold territory on May 19, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In of the 18 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for BIAF just turned positive on May 21, 2025. Looking at past instances where BIAF's MACD turned positive, the stock continued to rise in of 26 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BIAF advanced for three days, in of 100 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BIAF as a result. In of 64 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for BIAF crossed bearishly below the 50-day moving average on May 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BIAF broke above its upper Bollinger Band on May 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BIAF entered a downward trend on May 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.327) is normal, around the industry mean (24.191). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (55.249) is also within normal values, averaging (42.393).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BIAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BIAF is expected to report earnings to fall 37.31% to -10 cents per share on August 19

bioAffinity Technologies BIAF Stock Earnings Reports
Q2'25
Est.
$-0.10
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
The last earnings report on May 15 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 1.21M shares outstanding, the current market capitalization sits at 23.27M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
22211 W Interstate 10
Phone
+1 210 698-5334
Employees
14
Web
https://www.bioaffinitytech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DFH22.420.36
+1.63%
Dream Finders Homes
ATEN17.790.21
+1.19%
A10 Networks
OVID0.31N/A
+0.48%
Ovid Therapeutics
BNTX110.15-0.99
-0.90%
BioNTech SE American Depositary Share
DRTS2.81-0.13
-4.42%
Alpha Tau Medical Ltd

BIAF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BIAF has been loosely correlated with RSLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BIAF jumps, then RSLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIAF
1D Price
Change %
BIAF100%
-7.59%
RSLS - BIAF
48%
Loosely correlated
-12.01%
SNWV - BIAF
32%
Poorly correlated
+2.93%
HSCS - BIAF
29%
Poorly correlated
-5.29%
RDNT - BIAF
26%
Poorly correlated
+2.24%
TCMD - BIAF
25%
Poorly correlated
-0.30%
More